Literature DB >> 26968022

A One-Nearest-Neighbor Approach to Identify the Original Time of Infection Using Censored Baboon Sepsis Data.

Li Ang Zhang1, Robert S Parker, David Swigon, Ipsita Banerjee, Soheyl Bahrami, Heinz Redl, Gilles Clermont.   

Abstract

OBJECTIVES: Sepsis therapies have proven to be elusive because of the difficulty of translating biologically sound and effective interventions in animal models to humans. A part of this problem originates from the fact that septic patients present at various times after the onset of sepsis, whereas the exact time of infection is controlled in animal models. We sought to determine whether data mining longitudinal physiologic data in a nonhuman primate model of Escherichia coli-induced sepsis could help inform the time of onset of infection.
DESIGN: A nearest-neighbor approach was used to back cast the time of onset of infection in animal models of sepsis. Animal data were censored to simulate prospective monitoring at any moment along the septic infection. This was compared against an uncensored database to find the most similar animal in order to estimate the infection onset time. Leave-one-out cross-validation was used for validation. Biomarker selection was performed based on the criteria of estimation accuracy and/or ease of measurement.
SETTING: Computational experimental on existing experimental data.
SUBJECTS: Retrospective data from 33 septic baboons (Papio ursinus) subjected to Escherichia coli infusion. Validation was performed using 14 pigs that were subjected to surgically induced fecal peritonitis and 22 pigs that were subjected to lipopolysaccharide infusion.
MEASUREMENTS AND MAIN RESULTS: Longitudinal physiologic and serum markers, time of death. The presence of uniquely changing biomarkers during septic infection enabled the estimation of infection onset time in the datasets. Various combinations of temporal biomarkers, such as WBC, oxygen content, mean arterial pressure, and heart rate, yielded estimation accuracies of up to 97.8%. The use of temporal vital signs and a single measurement of serum biomarkers yielded highly accurate estimates without the need for invasive measurements. Validation in the pig data revealed similar results despite the heterogeneity of multiple experimental cohorts. This suggests that the method may be effective if sufficiently similar subjects are present in the database.
CONCLUSIONS: One nearest-neighbor analysis showed promise in accurately identifying the onset of infection given a database of known infection times and of sufficient breadth. We suggest that this approach is ready for evaluation within the clinical setting using human data.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26968022      PMCID: PMC5297595          DOI: 10.1097/CCM.0000000000001623

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  The dynamics of acute inflammation.

Authors:  Rukmini Kumar; Gilles Clermont; Yoram Vodovotz; Carson C Chow
Journal:  J Theor Biol       Date:  2004-09-21       Impact factor: 2.691

2.  A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration.

Authors:  Judy Day; Jonathan Rubin; Yoram Vodovotz; Carson C Chow; Angela Reynolds; Gilles Clermont
Journal:  J Theor Biol       Date:  2006-04-17       Impact factor: 2.691

3.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

4.  A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation.

Authors:  Angela Reynolds; Jonathan Rubin; Gilles Clermont; Judy Day; Yoram Vodovotz; G Bard Ermentrout
Journal:  J Theor Biol       Date:  2006-04-03       Impact factor: 2.691

5.  Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol.

Authors:  Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Ryan C Arnold; James M Horton; Jonathan R Studnek; Jeffrey A Kline; Alan E Jones
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

Review 6.  The disconnect between animal models of sepsis and human sepsis.

Authors:  Daniel Rittirsch; L Marco Hoesel; Peter A Ward
Journal:  J Leukoc Biol       Date:  2006-10-04       Impact factor: 4.962

Review 7.  Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier.

Authors:  Emanuel P Rivers; Anja Kathrin Jaehne; H Bryant Nguyen; Demosthenes G Papamatheakis; Daniel Singer; James J Yang; Samantha Brown; Howard Klausner
Journal:  Shock       Date:  2013-02       Impact factor: 3.454

Review 8.  Preclinical review of anti-tumor necrosis factor monoclonal antibodies.

Authors:  M Bodmer; M A Fournel; L B Hinshaw
Journal:  Crit Care Med       Date:  1993-10       Impact factor: 7.598

9.  A simple mathematical model of cytokine capture using a hemoadsorption device.

Authors:  Morgan V DiLeo; John A Kellum; William J Federspiel
Journal:  Ann Biomed Eng       Date:  2008-10-24       Impact factor: 3.934

10.  A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma.

Authors:  Prasong Khaenam; Darawan Rinchai; Matthew C Altman; Laurent Chiche; Surachat Buddhisa; Chidchamai Kewcharoenwong; Duangchan Suwannasaen; Michael Mason; Elizabeth Whalen; Scott Presnell; Wattanachai Susaengrat; Kimberly O'Brien; Quynh-Ahn Nguyen; Vivian Gersuk; Peter S Linsley; Ganjana Lertmemongkolchai; Damien Chaussabel
Journal:  J Transl Med       Date:  2014-03-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.